Four key considerations addressing the challenges for oral dosing with minitablet dispensing innovations.
Medicines
Author: Bjørn Knud Andersen - director, Front-End Innovation and Head Technology Accelerators and IPR, Phillips-Medisize, a Molex company.
When it comes to orally dosing solid tablets and/or capsules, certain patient populations such as paediatrics, geriatrics and oncology may find it a tough pill to swallow – quite literally. These patients often need highly flexible oral dosing based on their age, weight, body surface area or other variables. Alternative liquid dosing such as syrups pose some disadvantages, including the need for refrigeration, poor taste (especially for children) and the possibility of microbial contamination.